~/AI FOR SCIEN/infevo-secures-over-100m-rmb-in-pre-a-funding-for-virtual-cells

INFevo Secures Over 100M RMB in Pre-A Funding for Virtual Cells

AI for Science startup INFevo has completed a Pre-A funding round exceeding 100 million RMB, marking the largest single financing record for a virtual cell enterprise in China. The capital will be used to scale up its computational infrastructure and advance its AI-driven biological platforms. This funding highlights the growing investor confidence in computational biology and AI-driven drug discovery within China. By bridging the gap between theoretical AI predictions and physical wet-lab experiments, virtual cell models could drastically reduce the time and cost required for early-stage therapeutic development. INFevo introduced a Recursive Scientific Discovery framework to structure and reuse research hypotheses and experimental results. Additionally, its foundational transcriptomic virtual cell model, OCOO-T, achieved leading performance across three major single-cell perturbation benchmarks: Tahoe100M, Replogle, and PBMC.

## BACKGROUND

Virtual cells are computational models that utilize artificial intelligence and multi-omics data to simulate complex cellular behaviors and responses to genetic or pharmacological interventions. This emerging paradigm aims to replace or guide traditional biological experiments, helping researchers accelerate disease research and drug discovery.

## REFERENCES

## KEYWORDS

#AI for Science#Virtual Cell#Biotechnology#Venture Capital#Computational Biology

$ subscribe --daily

INFevo Secures Over 100M RMB in Pre-A Funding for Virtual Cells | Daily News